Inventor · disambiguated record
Vinay Bhaskar
Also filed as: BHASKAR VINAY
38 granted patents·8 pending applications·322 citations·filing 2003–2025
98Inventor score
Files withWEREWOLF THERAPEUTICS INC11TAKEDA PHARMACEUTICALS CO9FACET BIOTECH CORP8PDL BIOPHARMA INC4XOMA US LLC3
Top patents by PatentIndex Score
46 records- 0198US8362211B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2011·Granted Jan 29, 2013·71 cites·12 claims
- 0297US11414496B2Anti-CD38 binding domainsMILLENNIUM PHARM INC·Filed 2020·Granted Aug 16, 2022·4 cites·21 claims
- 0396US11352403B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Granted Jun 7, 2022·6 cites·13 claims
- 0496US10696724B2Activatable interleukin-2 polypeptidesWEREWOLF THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·18 cites·11 claims
- 0595US10696723B2Activatable interleukin 12 polypeptidesWEREWOLF THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·15 cites·12 claims
- 0695US9676869B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 13, 2017·12 cites·20 claims
- 0795US8926976B2ModulatorsCORBIN JOHN·Filed 2010·Granted Jan 6, 2015·30 cites·11 claims
- 0894US11535658B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2021·Granted Dec 27, 2022·2 cites·21 claims
- 0994US10494444B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 3, 2019·8 cites·10 claims
- 1094US10336833B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jul 2, 2019·9 cites·30 claims
- 1193US11981716B2Activatable interleukin-2 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2021·Granted May 14, 2024·2 cites·13 claims
- 1293US2025171561A1Anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1392US8926969B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Jan 6, 2015·14 cites·17 claims
- 1491US7674883B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Mar 9, 2010·6 cites·14 claims
- 1591US7662384B2Use of anti-α5β1 antibodies to inhibit cancer cell proliferationFACET BIOTECH CORP·Filed 2005·Granted Feb 16, 2010·21 cites·13 claims
- 1691US7288248B2Antibodies against cancer antigen TMEFF2 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 30, 2007·27 cites·7 claims
- 1790US9790285B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 17, 2017·7 cites·24 claims
- 1890US9102744B2Conjugated anti-CD38 antibodiesELIAS KATHLEEN ANN·Filed 2011·Granted Aug 11, 2015·13 cites·17 claims
- 1989US9944698B2ModulatorsXOMA TECHNOLOGY LTD·Filed 2014·Granted Apr 17, 2018·5 cites·17 claims
- 2088US7276589B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisPDL BIOPHARMA INC·Filed 2003·Granted Oct 2, 2007·23 cites·9 claims
- 2187US7807163B2Antibodies against GPR64 and uses thereofFACET BIOTECH CORP·Filed 2008·Granted Oct 5, 2010·7 cites·37 claims
- 2286US11261247B2ModulatorsXOMA US LLC·Filed 2018·Granted Mar 1, 2022·2 cites·16 claims
- 2385US12209138B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jan 28, 2025·0 cites·17 claims
- 2484US7824678B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Nov 2, 2010·4 cites·9 claims
- 2582US7276372B2Antibodies against GPR64 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 2, 2007·12 cites·20 claims
- 2681US7785816B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Aug 31, 2010·2 cites·4 claims
- 2780US12371488B2ModulatorsXOMA US LLC·Filed 2022·Granted Jul 29, 2025·0 cites·13 claims
- 2878US12275769B2Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Granted Apr 15, 2025·0 cites·14 claims
- 2978US11434304B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 6, 2022·0 cites·28 claims
- 3078US9725510B2ModulatorsXOMA (US) LLC·Filed 2014·Granted Aug 8, 2017·1 cites·20 claims
- 3176US12312411B2Anti-CD38 binding domainsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted May 27, 2025·0 cites·20 claims
- 3275US11739132B2Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·0 cites·16 claims
- 3374US2025179138A1Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3474US2023272028A1Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3572US2020031951A1Conjugated anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 3670US11453710B2Activatable interleukin 12 polypeptides and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·0 cites·16 claims
- 3766US8309084B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisRAMAKRISHNAN VANITHA·Filed 2011·Granted Nov 13, 2012·1 cites·6 claims
- 3864US7879987B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisFACET BIOTECH CORP·Filed 2007·Granted Feb 1, 2011·0 cites·11 claims
- 3964US7776585B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisFACET BIOTECH CORP·Filed 2007·Granted Aug 17, 2010·0 cites·11 claims
- 4064US7547544B2Antibodies against GPR64 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Jun 16, 2009·0 cites·18 claims
- 4163US7897148B2Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesisABBOTT BIOTHERAPEUTICS CORP·Filed 2007·Granted Mar 1, 2011·0 cites·8 claims
- 4262US2021115102A1Separation moieties and methods of use thereofWEREWOLF THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4358US2010291111A1Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell ProliferationFACET BIOTECH·Filed 2009·Application pending·0 cites
- 4452US8257708B2Antibodies against cancer antigen TMEFF2 and uses thereofBHASKAR VINAY·Filed 2010·Granted Sep 4, 2012·0 cites·21 claims
- 4548US2008181903A1Conjugate of natriuretic peptide and antibody constant regionPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 4644US2009041767A1Pharmaceutical combinationsRAMAKRISHNAN VANITHA·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vinay Bhaskar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →